Who Should Not Receive the Cervical Cancer Vaccine?
Mar 20, 2022
Source: Cainiu Health
Dr. Chen Zhe
Introduction
In general, healthy women are eligible for the HPV vaccine, and receiving it within the recommended age range ensures optimal efficacy. However, the following four groups of individuals are not advised to receive the HPV vaccine: those with known allergies to vaccine components, pregnant women, women actively trying to conceive, women menstruating at the time of vaccination, and women with pre-cancerous cervical lesions—primarily to avoid compromising vaccine effectiveness or increasing the risk of adverse reactions.
Cervical cancer is profoundly frightening for women, and the cervical cancer vaccine has significantly reduced the risk of developing this disease—drawing widespread public attention. Many women wish to receive this vaccine as a preventive measure against cervical cancer. However, the vaccine is not universally suitable for all individuals, and certain contraindications exist for its administration. So, who should not receive the cervical cancer vaccine? Let’s explore this together.
Who Should Not Receive the Cervical Cancer Vaccine?
1. Allergy: Women with known allergies to certain components—such as proteins or yeast—should avoid receiving the cervical cancer vaccine. Since the vaccine contains protein and yeast-derived ingredients, administration may heighten the risk of allergic reactions, potentially causing unnecessary harm to health.
2. Pregnant Women and Those Planning Pregnancy: Vaccination is not recommended during pregnancy, as it may adversely affect fetal growth and development. This precaution also applies to women actively planning conception. If pregnancy is discovered unexpectedly after vaccination, termination or induction should not be rushed. Instead, women intending pregnancy, those who are pregnant, or those who are breastfeeding should postpone or temporarily discontinue vaccination until after completion of pregnancy and lactation.
3. Women During Menstruation: Immune function naturally declines during menstruation. Many women experience adverse reactions following cervical cancer vaccination—including dizziness, fatigue, and abdominal pain. Therefore, vaccination is best scheduled for after menstruation concludes.
4. Women with Precancerous Cervical Lesions or Cervical Cancer: The vaccine is not recommended for women diagnosed with cervical cancer or those with precancerous cervical lesions. In such cases, vaccination offers no therapeutic benefit and may provoke adverse effects. At this stage, prompt and active collaboration with healthcare providers is essential—optimal treatment options include surgery, chemotherapy, and/or radiotherapy.
The above four groups should generally avoid receiving the cervical cancer vaccine—please take note. As cervical cancer poses a serious threat to women’s lives, proactive prevention is vital. If you suspect any symptoms or risk factors, consult a healthcare provider promptly for screening and early exclusion of cervical cancer.
